153 related articles for article (PubMed ID: 23326427)
1. 3,3'-Diindolylmethane protects against cardiac hypertrophy via 5'-adenosine monophosphate-activated protein kinase-α2.
Zong J; Deng W; Zhou H; Bian ZY; Dai J; Yuan Y; Zhang JY; Zhang R; Zhang Y; Wu QQ; Guo HP; Li HL; Tang QZ
PLoS One; 2013; 8(1):e53427. PubMed ID: 23326427
[TBL] [Abstract][Full Text] [Related]
2. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
3. Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-α.
Deng W; Zong J; Bian Z; Zhou H; Yuan Y; Zhang R; Guo H; Zhang Y; Shen D; Li H; Tang Q
Mol Nutr Food Res; 2013 Sep; 57(9):1680-7. PubMed ID: 23625645
[TBL] [Abstract][Full Text] [Related]
4. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
Wang HB; Duan MX; Xu M; Huang SH; Yang J; Yang J; Liu LB; Huang R; Wan CX; Ma ZG; Wu QQ; Tang QZ
J Cell Mol Med; 2019 Aug; 23(8):5715-5727. PubMed ID: 31225721
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
[TBL] [Abstract][Full Text] [Related]
7. Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway.
Ma ZG; Dai J; Wei WY; Zhang WB; Xu SC; Liao HH; Yang Z; Tang QZ
Int J Biol Sci; 2016; 12(7):861-71. PubMed ID: 27313499
[TBL] [Abstract][Full Text] [Related]
8. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
9. Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
Zong J; Zhang DP; Zhou H; Bian ZY; Deng W; Dai J; Yuan Y; Gan HW; Guo HP; Tang QZ
J Cell Biochem; 2013 May; 114(5):1058-65. PubMed ID: 23225340
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation.
Fu YN; Xiao H; Ma XW; Jiang SY; Xu M; Zhang YY
Acta Pharmacol Sin; 2011 Jul; 32(7):879-87. PubMed ID: 21552292
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
Liu ZH; Liu HB; Wang J
Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
[TBL] [Abstract][Full Text] [Related]
16. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
17. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Li F; Zhang N; Wu Q; Yuan Y; Yang Z; Zhou M; Zhu J; Tang Q
Int J Mol Med; 2017 Jan; 39(1):199-207. PubMed ID: 27959392
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
19. Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
Deng W; Jiang D; Fang Y; Zhou H; Cheng Z; Lin Y; Zhang R; Zhang J; Pu P; Liu Y; Bian Z; Tang Q
J Mol Histol; 2013 Oct; 44(5):575-85. PubMed ID: 23719775
[TBL] [Abstract][Full Text] [Related]
20. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.
Moellmann J; Mann PA; Kappel BA; Kahles F; Klinkhammer BM; Boor P; Kramann R; Ghesquiere B; Lebherz C; Marx N; Lehrke M
Diabetes Obes Metab; 2022 Nov; 24(11):2263-2272. PubMed ID: 35801343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]